Category : Dysbiosis

Pediatric acute-onset neuropsychiatric syndrome (PANS) refers to a clinical spectrum of neuropsychiatric disorders triggered by environmental conditions, metabolic disorders and/or infections, which may increase children’s risk of sleep disturbances and mood disorders. A specific subset within the broader clinical spectrum of PANS includes pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections syndrome (PANDAS). An increasing amount of research is focusing…

GMFH Editing Team
GMFH Editing Team

Pediatric acute-onset neuropsychiatric syndrome (PANS) refers to a clinical spectrum of neuropsychiatric disorders triggered by environmental conditions, metabolic disorders and/or infections, which may increase children’s risk of sleep disturbances and mood disorders. A specific subset within the broader clinical spectrum of PANS includes pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections syndrome (PANDAS). An increasing amount of research is focusing…

GMFH Editing Team
GMFH Editing Team

Recent observational data in infants (here; here) suggest a developmental origin for childhood atopy and subsequent asthma involving the gut microbiome perturbation and associated metabolic dysfunction in early life. However, little is known regarding gut microbiota maturation over the first year of life in infants at high risk for asthma and whether targeting the gut microbiome may modify disease risk.…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Recent observational data in infants (here; here) suggest a developmental origin for childhood atopy and subsequent asthma involving the gut microbiome perturbation and associated metabolic dysfunction in early life. However, little is known regarding gut microbiota maturation over the first year of life in infants at high risk for asthma and whether targeting the gut microbiome may modify disease risk.…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Both diet and medications are among the strongest variables affecting the gut microbiome. When it comes to medications, although antibiotics have been repeatedly shown to affect the human gut microbiome, little is known regarding the impact of non-antibiotic prescription drugs on the gut microbiome. A review, led by Dr. Emmanuel Montassier from the MiHAR Lab at Institut de Recherche en…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Both diet and medications are among the strongest variables affecting the gut microbiome. When it comes to medications, although antibiotics have been repeatedly shown to affect the human gut microbiome, little is known regarding the impact of non-antibiotic prescription drugs on the gut microbiome. A review, led by Dr. Emmanuel Montassier from the MiHAR Lab at Institut de Recherche en…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.
Gut Bacteria

Although previous research has shown that both diet and medications are the primary factors involved in the modulation of both structural and functional capacity of the human gut microbiota, dietary intervention studies often do not show reliable changes in the gut microbiota from an intervention. A review, led by Dr. Genelle Healey from the Massey Institute of Food Science and…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Gut Bacteria

Although previous research has shown that both diet and medications are the primary factors involved in the modulation of both structural and functional capacity of the human gut microbiota, dietary intervention studies often do not show reliable changes in the gut microbiota from an intervention. A review, led by Dr. Genelle Healey from the Massey Institute of Food Science and…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Gut Microbiota for Health is pleased to present its “Year at a Glance 2017” document! With an editorial from Prof. Fernando Azpiroz, Head of the Gut Microbiota & Health section of the European Society of Neurogastroenterology and Motility (ESNM), Vienna (Austria), this report summarizes the important breakthroughs in gut microbiota research in 2017. The last year has been a special…

GMFH Editing Team
GMFH Editing Team

Gut Microbiota for Health is pleased to present its “Year at a Glance 2017” document! With an editorial from Prof. Fernando Azpiroz, Head of the Gut Microbiota & Health section of the European Society of Neurogastroenterology and Motility (ESNM), Vienna (Austria), this report summarizes the important breakthroughs in gut microbiota research in 2017. The last year has been a special…

GMFH Editing Team
GMFH Editing Team

Although previous observational research has found that type 2 diabetes (T2D) is related to gut dybsiosis, a causal link between gut microbial dysbiosis and T2D development has not yet been proven. Besides this, it has been reported that treatment with Metformin-a commonly prescribed drug for the treatment of individuals with T2D- may confer metabolic benefits through alteration of the gut…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Although previous observational research has found that type 2 diabetes (T2D) is related to gut dybsiosis, a causal link between gut microbial dysbiosis and T2D development has not yet been proven. Besides this, it has been reported that treatment with Metformin-a commonly prescribed drug for the treatment of individuals with T2D- may confer metabolic benefits through alteration of the gut…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) in which both genetic and environmental factors (including age and microbial infections) can contribute to the dysregulation of immune tolerance. Although recent studies have suggested that alterations in the gut microbiota (dysbiosis) are related to MS, it is still unknown how gut dysbiosis impacts the onset and…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) in which both genetic and environmental factors (including age and microbial infections) can contribute to the dysregulation of immune tolerance. Although recent studies have suggested that alterations in the gut microbiota (dysbiosis) are related to MS, it is still unknown how gut dysbiosis impacts the onset and…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

When Leo Tolstoy wrote the first line of his classic novel Anna Karenina—“All happy families are like one another; each unhappy family is unhappy in its own way"—he probably never thought it would apply to gut microbiomes. But researchers from University of Washington (USA) and Oregon State University (USA) recently put forward the "Anna Karenina principle" as a way of…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

When Leo Tolstoy wrote the first line of his classic novel Anna Karenina—“All happy families are like one another; each unhappy family is unhappy in its own way"—he probably never thought it would apply to gut microbiomes. But researchers from University of Washington (USA) and Oregon State University (USA) recently put forward the "Anna Karenina principle" as a way of…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Previous studies have found that ageing is related to decreased gut microbiota diversity and increased opportunistic pathogens together with a low-grade inflammatory state, which may lead to an increased morbidity and frailty. By contrast, long-lived people appear to have a gut microbiota profile enriched in beneficial bacteria involved in the production of short-chain fatty acids. Although hospitalized elderly people are…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Previous studies have found that ageing is related to decreased gut microbiota diversity and increased opportunistic pathogens together with a low-grade inflammatory state, which may lead to an increased morbidity and frailty. By contrast, long-lived people appear to have a gut microbiota profile enriched in beneficial bacteria involved in the production of short-chain fatty acids. Although hospitalized elderly people are…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados